Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: Study protocol of a randomised, double-blinded, placebo-controlled clinical trial

Kerstin K. Antonsen, Mette K. Klausen, Amanda S. Brunchmann, Nina Le Dous, Mathias E. Jensen, Kamilla Woznica Miskowiak, Patrick M. Fisher, Gerda K. Thomsen, Henrik Rindom, Thomas P. Fahmy, Sabine Vollstaedt-Klein, Helene Benveniste, Nora D. Volkow, Ulrik Becker, Claus Ekstrøm, Gitte Moos Knudsen, Tina Vilsbøll, Anders Fink-Jensen*

*Corresponding author for this work

    Research output: Contribution to journalJournal articleResearchpeer-review

    187 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: Study protocol of a randomised, double-blinded, placebo-controlled clinical trial'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Neuroscience